面膜现“黄色污物”！消费者维权陷困境，可复美再陷质量争议

Core Viewpoint - The incident involving a consumer's complaint about a facial mask highlights a trust crisis within the beauty industry, particularly regarding product quality and consumer safety [1][4]. Company Overview - The company in question, Xi'an Juzhi Biological Technology Co., Ltd., was established in 2000 and went public on the Hong Kong Stock Exchange in 2022. It owns several brands, including Kefu Mei and Keli Jin, with Kefu Mei being a major product line [10]. - The company reported a revenue of 5.539 billion yuan for 2024, reflecting a year-on-year growth of 57.2%, and a net profit of 2.062 billion yuan, up 42.1% year-on-year. Kefu Mei accounted for 82% of the total revenue, with its sales increasing by 62.9% to 4.542 billion yuan [10]. Industry Context - The beauty industry is currently facing significant scrutiny over product safety and quality, as evidenced by multiple complaints against Juzhi Biological, including allegations of misleading advertising and unapproved ingredients [10]. - The company's research and development (R&D) investment appears to be insufficient, with an R&D expense ratio of only 1.9% in 2024, down from 2.1% in 2023. In comparison, competitors like Jinbo Biological, Huaxi Biological, and Beitaini have R&D expense ratios of 10.89%, 6.8%, and 6.07%, respectively [10].